Hemant Mourya, Rajendra Chauhan, Ramakant Joshi, Wasim Akram, Navneet Garud
Hemant Mourya1, Rajendra Chauhan1, Ramakant Joshi2, Wasim Akram3, Navneet Garud1
1School of Studies in Pharmaceutical Sciences, Jiwaji University, Gwalior (M.P) – 474011.
2Institute of Pharmaceutical Research, GLA University, Mathura (U.P) – 281406.
3Amity Institute of Pharmacy, Amity University, Gwalior (M.P) – 474005.
Volume - 16,
Issue - 5,
Year - 2023
The bilayer tablet heralds a new chapter in the development of controlled-release formulations with a wide range of properties that result in an effective drug delivery technique. Controlled release dosage forms have been commonly used to increase the treatment of a variety of important drugs. Uses of bilayer tablets for anti-inflammatory and analgesic purposes are a unique feature. Bilayer tablets are useful for releasing two medications in sequence, separating two incompatible chemicals, and creating a sustained-release tablet with the first layer of immediate-release as the initial dose and the second layer as the maintenance dose. The bilayer tablet is a more modern technology that corrects the flaws of single-layer tablets. The objective of this paper is to highlight the obstacles that arise during the preparation of bilayer tablets, as well as to suggest solutions to these issues. To better comprehend bilayer tablets, kinds such as single side press, double side press, and bilayer tablet displacement press are discussed, as well as uses, pros, and disadvantages. Its drug companies have become more interested in mixing two or more APIs (active pharmaceutical ingredients) in a single dosage form to improve patient convenience and compliance throughout the last decade. Many pharmaceutical industries are now working on bi-layer tablets for a variety of purposes, including patent extension, therapeutics, and advertising. This article provides an introduction of bilayer tablet technology, highlighting the key benefits of this type of oral dosage form while also describing current issues and developments in production techniques and the quality of products. The current report covers a variety of elements of bilayer tablets.
Cite this article:
Hemant Mourya, Rajendra Chauhan, Ramakant Joshi, Wasim Akram, Navneet Garud. Bilayer Tablets: A Promising Novel Drug Delivery System. Research Journal of Pharmacy and Technology 2023; 16(5):2517-1. doi: 10.52711/0974-360X.2023.00414
Hemant Mourya, Rajendra Chauhan, Ramakant Joshi, Wasim Akram, Navneet Garud. Bilayer Tablets: A Promising Novel Drug Delivery System. Research Journal of Pharmacy and Technology 2023; 16(5):2517-1. doi: 10.52711/0974-360X.2023.00414 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-73
1. Mohideen S and Satyanarayana T. “Development and evaluation of two-layered tablets of glimepiride and metformin hydrochloride for thetreatmentofhyperglycemia.”InterJBioPharma.2011;2(1):3135.https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.1037.7697&rep=rep1&type=pdf
2. Yadav A and Jain DK. Formulation development and in vitro characterization of player and floating bioadhesive tablets of propranolol hydrochloride.Asia J Phar Life Scie.2011;1(1):2
3. Dey S and Chatto PS. Formulation and evaluation of a fixed-dose combination of bilayer gastro retentive matrix tablet containing atorvastatin as fast release and atenolol as the sustained release. BiomedRes Inter. 2014;10(1155):396106. DOI: https://doi.org/10.1155/2014/396106
4. Abhishek Kumar Singh, Kasif Shakeel. Formulation and Evaluation of Immediate Release Tablets of Etizolam. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(4):281-4.
5. Sonali Joshi, Aarti Jaybhaye, Ganesh Deshmukh. Bilayer Tablet Technology: A Novel Approach. Research J. Pharm. and Tech. 6(12): Dec. 2013; Page 1443-1451.
6. Banu H and Sahariar MR. Formulation development of bi-layer acetaminophen tablets for extended drug release.J Chem Pharm Res.2011;3(6):348360.https://www.researchgate.net/profile/IrinDewan/publication/264096078_Formulation_development_of_bilayer_acetaminophen_tablets_for_extended_drug_release/links/0f31753ce38e545676000000/Formulation-development-of-bi-layer-acetaminophen-tablets-for-extended-drug-release.pdf
7. Muneeba A, Muhammad J “Bilayer tablets: A developing novel drug delivery system” Journal of Drug Delivery Science and Technology 60 (2020) 102079 DOI: https://doi.org/10.1016/j.jddst.2020.102079
8. Sadhana RS and Vidya MM. Development and evaluation of bilayer floating tablets of diltiazem HCl. Inter J Pharm Pharm Scien.2014;6(2):62-65. https://web.archive.org/web/20180412212753id_/http://ijppsjournal.com/Vol6Issue2/7896.pdf
9. Musharraf Chauhan, Shakti Suthar, Ankur Shah, Misam Polara, Manish Patel, Jayvadan Patel. Bilayer tablet: Immediate Release and Sustain Release: A Review. Research J. Pharm. and Tech. 5(6): June 2012; Page 716-720.
10. Sharma V, Nagpal M, Jain UK, Mangotia A, and Kumar R. Antidiabetic drug and combination therapy. ARPB. 2013;3(2):389-394. DOI: 10.1.1.403.7326
11. Bogan, R.K. Treatment options for insomnia—pharmacodynamics of zolpidem extended-release to benefit next-day performance. Postgrad. Med. 2008; 120: 161–171. DOI:https://doi.org/10.3810/pgm.2008.09.1916
12. Kulkarni A., Bhatia M. Development and evaluation of bilayer floating tablets of atenolol and lovastatin for biphasic release profile. Iran. J. Pharm. Res. 2009; 8: 15–25. https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=138061
13. Nirmal J., Saisivam S., Peddanna C., Muralidharan S., Nagarajan M., et al. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chem. Pharm. Bull. 2008; 56: 1455–1458. DOI: https://doi.org/10.1248/cpb.56.1455
14. Gattani SG, Khabiya SS, Amrutkar JR and KushareSS. Formulation and evaluation of bilayer tablets of metoclopramide hydrochloride and diclofenac sodium. P DAJ Pharm Scien Technol. 2012;66(2):151-60. DOI: https://doi.org/10.5731/pdajpst.2012.00641
15. Reddy RK and Srinivas N. Formulation and evaluation of bilayered tablets of losartan potassium. IP. 2014;2(1):312-320. http://www.innpharmacotherapy.com/volumearticles/fulltextpdf/63_3ippsajan2014.pdf
16. Sandeep N and Gupta MM. Immediate drug release dosage forms a review. JDDT. 2013;3(2):155-161. DOI: https://doi.org/10.22270/jddt.v3i2.457
17. .Katare Varsha B., Bhutkar M. A., Kumbhar A. P., Pol S. K., Katare P. B. Formulation and Evaluation of Sustained Release Matrix Tablets of Pregabalin. Research J. Pharm. and Tech. 6(11): November 2013; Page 1190-1194.
18. SH Lakade, MR Bhalekar. Formulation and Evaluation of Sustained Release Matrix Tablet of Anti-Anginal Drug, Influence of Combination of Hydrophobic and Hydrophlic Matrix Former. Research J. Pharm. and Tech. 1(4): Oct.-Dec. 2008;Page 410-413.
19. Pateriya A, Bhowmick M, Pandey GK, Joshi A, and Dubey BR. Formulation and evaluation of player tablets of candesartan and hydrochlorothiazide for the treatment of hypertension. JDDT. 2013;3(6):21-35.
20. Kumar HG, Jaganathan K, Kumar SR and Peruma lP. Formulation and in-Vitro evaluation of bilayer floating tablets of metformin hydrochloride and sitagliptin phosphate. Intern J Pharma Resea. 2013; 5(1):53-59. http://repository-tnmgrmu.ac.in/id/eprint/621
21. Mridanga Raj Ray, Sekhar Kumar Bose, Koushik Sengupta. Design, Development and In Vitro Evaluation of Directly Compressed Sustained Release Matrix Tablet of Famotidine. Research J. Pharm. and Tech. 1(3): July-Sept. 2008; Page 175-178.
22. Prabhakara P, Harish NM, Gulzar Ahmed M, Narayana Charyulu R, Santhosh P, Satyanarayana D, Subrahmanyam EVS. Formulation and In Vitro Evaluation of Sustained Release Tablets of Domperidone. Research J. Pharm. and Tech.2 (2): April.-June.2009,; Page 358-362.
23. Deshpander,gowdad.v.“bi-layertablets-anemergingtrend:areview” international journal of pharmaceutical sciences and research, 2011; vol. 2(10): 2534-2544. DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.2(10).2534-44
24. Joshi R, Garud N and Akram W: Fast dissolving tablets: a review. Int J Pharm Sci & Res 2020; 11(4): 1562-70. DOI: 10.13040/IJPSR. 0975-8232.11(4).1562-70.
25. Chaudhari S, Bawaskar M and Shirsat A. Formulation and evaluation of player floating tablet of carvedilol phosphate. JDDT. 2012;2(5):9-19. DOI: https://doi.org/10.22270/jddt.v2i5.305
26. Nirmal J, Saisivam S, Peddanna C, Muralidharan S and Nagarajan M. (2008). Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chemical and Pharmaceutical Bulletin, 56, 1455–1458. DOI: https://doi.org/10.1248/cpb.56.1455
27. Singh BN, Kim KH. Floating drug delivery systems an approach to oral controlled drug delivery via gastric retention, J Control Rel
2000, 63, p.235-59. DOI: https://doi.org/10.1016/S0168-3659(99)00204-7
28. Atram SC, Udavant YK, Salunke RJ, Neb GB, Shahi SR, Gulecha BS, Padalkar AN. Formulation and evaluation of bilayer tablet
containing Metoprolol succinate and Amlodipine besylate as a model drug for anti-hypertensive therapy. J Pharm Res 2009;2(8):1335-47. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.736.8974&rep=rep1&type=pdf
29. Mukund G Tawar , Pawar M D, P D Chaudhari. Development and Evaluation of Tramadol Hydrochloride Sustained Release Tablet. Research J. Pharm. and Tech.2 (3): July-Sept. 2009,;Page 470-473.
30. M. Manikandan, K. Kannan, S. Selvamuthukumar, R. Manavalan. Design, Development and Evaluation of Metformin Hydrochloride and Glimepiride Immediate Release Tablets. Research J. Pharm. and Tech. 5(4): April 2012; Page 547-552.
31. Laxmikant R Zawar, Anjul S Gupta, Pradyumna P Ige, Sanjay B Bari. Design and Development of Directly Compressed Sustained Release Matrix Tablets of Aceclofenac. Research J. Pharm. and Tech. 3(1): Jan. - Mar. 2010; Page 168-174.